Given that the expression of CyPA and CD147 is significantly different in different grades of glioma and related to glioma recurrence, we believe that CyPA and CD147 could be potential biomarkers facilitating glioma categorization before surgery and further indicating prognosis. Here, BSG is linked to glioma.